Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-04-14
1999-06-15
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C07C21900
Patent
active
059122250
ABSTRACT:
Biodegradable polymers are described comprising the recurring monomeric units shown in formula I: ##STR1## wherein: R is selected from the group consisting of H, alkyl, aryl or heterocyclic; and
REFERENCES:
patent: 3927231 (1975-12-01), Desitter et al.
patent: 3932566 (1976-01-01), Reader
patent: 4259222 (1981-03-01), Login et al.
patent: 4315847 (1982-02-01), Login et al.
patent: 4315969 (1982-02-01), Login et al.
patent: 4638045 (1987-01-01), Kohn et al.
patent: 5099060 (1992-03-01), Kohn et al.
patent: 5194581 (1993-03-01), Leong
patent: 5219564 (1993-06-01), Zalipsky et al.
patent: 5256765 (1993-10-01), Leong
patent: 5530093 (1996-06-01), Engelhardt et al.
Langer et al., "Controlled Release of Bioactive Agents", Rev. Macro. Chem. Phys., C23(1), 61-125 (1983).
Chien, Y.W. et al., Novel Drug Delivery Systems (1982).
Ertel et al., "Evaluation of Poly(DTH Carbonate), a Tyrosine-derived Degradable Polymer, for Orthopedic Applications", Journal of Biomedical Materials Research, 29:1337-48 (1995).
Choueka et al., "Canine Bone Response to Tyrosine-derived Polycarbonates and Poly(L-lactic Acid)", Journal of Biomedical Materials Research, 31:35-41 (1996).
Leong et al., "Polyanhydrides for Controlled Release of Bioactive Agents", Biomaterials, 7:364 (1986).
Controlled Release of Bioactive Materials (Baker et al. ed. 1980).
Bruin et al., "Biodegradable Lysine Diisocyanate-based Poly(glycolide-co-.epsilon.-caprolactone)-urethane Network in Artificial Skin", Biomaterials, 11 (4) :291-95 (1990).
Penczek et al., "Phosphorus-Containing Polymers", Handbook of Polymer Synthesis, Part B, Chpt. 17, 1077-1132 (Kricheldorf ed. 1992).
Kadiyala et al., "Poly(phosphoesters): Synthesis, Physico-chemical Characterization and Biological Response", Biomedical Applications of Synthetic Biodegradable Polymers, Chpt. 3, 33-55 (Hollinger ed. 1995).
Leong Kam W.
Mao Hai-quan
Delaney Patrick R.
Johns Hopkins Univ. School of Medicine
Taft Kingsley
Tsang Cecilia J.
Vinceint Matthew P.
LandOfFree
Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine e does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine e will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-402489